← Back to Search

Prevention Strategies for HIV Among At-risk Latinos

N/A

Waitlist Available

Led By Laura R Glasman

Research Sponsored by Medical College of Wisconsin

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up past 12 months

Awards & highlights

Study Summary

This trial is testing if a network intervention can help Latino men who have sex with men and transwomen get regular HIV tests and prevent HIV transmission.

Who is the study for?

This trial is for Latino men who have sex with men and transwomen over 18 years old, living in Milwaukee, Cleveland, or Indianapolis. Participants must be able to consent and belong to a network where at least 80% are of Latinx descent. Cisgender females and those not identifying as homosexual or bisexual cannot join.Check my eligibility

What is being tested?

The study tests the effectiveness of HIV prevention strategies among friendship networks through regular testing, risk reduction counseling, PrEP awareness, and referrals. It's a randomized controlled trial comparing these interventions within selected communities.See study design

What are the potential side effects?

Since this trial focuses on counseling and education rather than medication or medical procedures, there may not be direct physical side effects; however participants might experience emotional distress or anxiety related to discussing personal behaviors associated with HIV risk.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ past 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~past 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and past 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Mean percentage of PrEP-eligible participants who report having consulted with a provider about PrEP.

Mean percentage of participants who report having had unprotected sex with a casual partner.

Mean percentage of participants who report having tested for HIV in the past 6 months.

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Standard of Care plus Network InterventionExperimental Treatment2 Interventions

Network intervention

Group II: Standard of CareActive Control1 Intervention

HIV counseling and testing

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

HIV counseling and testing

2012

N/A

~490

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH

2,783 Previous Clinical Trials

2,688,671 Total Patients Enrolled

Medical College of WisconsinLead Sponsor

609 Previous Clinical Trials

1,162,127 Total Patients Enrolled

Laura R GlasmanPrincipal InvestigatorMedical College of Wisconsin

Media Library

HIV counseling and testing Clinical Trial Eligibility Overview. Trial Name: NCT04563715 — N/A

Human Immunodeficiency Virus Infection Research Study Groups: Standard of Care, Standard of Care plus Network Intervention

Human Immunodeficiency Virus Infection Clinical Trial 2023: HIV counseling and testing Highlights & Side Effects. Trial Name: NCT04563715 — N/A

HIV counseling and testing 2023 Treatment Timeline for Medical Study. Trial Name: NCT04563715 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this research project still open?

"According to information published on clinicaltrials.gov, this research endeavour has ceased recruitment for the time being. Initially posted in November of 2020 and last updated on November 2021, 484 other studies are currently searching for participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

HIV Prevention Among At-risk Latinos in the Heartland

Laura R. Glasman 2020. "HIV Prevention Among At-risk Latinos in the Heartland". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04563715.

All > Hiv Infection